Skip to main content

Table 6 Drug prescriptions for facial palsy

From: Analysis of medical services provided to patients with peripheral facial palsy in Korea: a descriptive, cross-sectional study of the health insurance review and assessment service national patient sample database

  Total Outpatientsa Inpatientsb
Total Users of both WM users Total Users of both WM users Total Users of both WM users
N % N % N % N % N % N % N % N % N %
  4970 1068 1114 4690 1002 1057 519 88 324
Prednisolone 852 17.1 607 56.8 245 22.0 750 16.0 529 52.8 221 20.9 200 38.5 34 38.6 166 51.2
Methylprednisolone 230 4.6 168 15.7 62 5.6 176 3.8 130 13.0 46 4.4 67 12.9 13 14.8 54 16.7
Famciclovir 189 3.8 145 13.6 44 3.9 150 3.2 119 11.9 31 2.9 47 9.1 12 13.6 35 10.8
Mecobalaminc 183 3.7 123 11.5 60 5.4 174 3.7 117 11.7 57 5.4 19 3.7 1 1.1 18 5.6
Sodium hyaluronatec 175 3.5 134 12.5 41 3.7 131 2.8 98 9.8 33 3.1 51 9.8 8 9.1 43 13.3
Dexamethasone 171 3.4 105 9.8 66 5.9 126 2.7 73 7.3 53 5.0 47 9.1 8 9.1 39 12.0
Paracetamol 131 2.6 85 8.0 46 4.1 89 1.9 54 5.4 35 3.3 49 9.4 11 12.5 38 11.7
Valaciclovir 116 2.3 81 7.6 35 3.1 93 2.0 67 6.7 26 2.5 31 6.0 4 4.5 27 8.3
Aciclovir 103 2.1 73 6.8 30 2.7 86 1.8 61 6.1 25 2.4 23 4.4 3 3.4 20 6.2
Choline alfoscerate 95 1.9 46 4.3 49 4.4 83 1.8 36 3.6 47 4.4 15 2.9 1 1.1 14 4.3
Diazepam 88 1.8 35 3.3 53 4.8 80 1.7 28 2.8 52 4.9 11 2.1 1 1.1 10 3.1
Acetylsalicylic acid 83 1.7 26 2.4 57 5.1 58 1.2 17 1.7 41 3.9 32 6.2 0 0.0 32 9.9
Eperisone 81 1.6 37 3.5 44 3.9 64 1.4 29 2.9 35 3.3 21 4.0 2 2.3 19 5.9
Alprazolam 76 1.5 35 3.3 41 3.7 61 1.3 23 2.3 38 3.6 16 3.1 3 3.4 13 4.0
Loxoprofen sodiumc 73 1.5 36 3.4 37 3.3 69 1.5 34 3.4 35 3.3 4 0.8 1 1.1 3 0.9
Ginkgo biloba 71 1.4 33 3.1 38 3.4 62 1.3 25 2.5 37 3.5 9 1.7 2 2.3 7 2.2
Acetylcarnitine 59 1.2 31 2.9 28 2.5 45 1.0 25 2.5 20 1.9 19 3.7 3 3.4 16 4.9
Amitriptyline 49 1.0 25 2.3 24 2.2 37 0.8 18 1.8 19 1.8 14 2.7 1 1.1 13 4.0
Clopidogrel 44 0.9 12 1.1 32 2.9 32 0.7 5 0.5 27 2.6 18 3.5 0 0.0 18 5.6
  1. WM Western medicine
  2. aOutpatients: Patients with at least one outpatient visit
  3. bInpatients: Patients who used inpatient services at least once
  4. cAnatomical Therapeutic Chemical fourth level medication